Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by Emili0on Apr 14, 2016 12:07am
314 Views
Post# 24764961

RE:RE:RE:RE:RE:WE ARE ALMOST THERE....

RE:RE:RE:RE:RE:WE ARE ALMOST THERE....
Let's assume Q4 2015 financials show about $375k and Q1 2016 financials show around $800k, considering new sales staff and otc products we can easily see 5-6 million for the 2016 year. Now when we look at the Q3 margins we see around 53% returns, I'm not expecting maybe that high of a number but I highly doubt we will see anything much lower than 25%. You do the math. At these trading levels Vanc is a steal and in my opinion has been totally derisked. I'm all in baby! Vanc will be a huge success. But this isn't just a quick play this is the real deal, one for the long haul.  With sales ramping up, the share price will soon follow. If you want to maximize profits than you need to hang on for at least 3-5 years to let this puppy mature. The cherry on the top would be a buyout at the end. This is going to be one H E L L of a ride, so buckle up and hold on.
See you at the AGM on June 22.
Emili0
Bullboard Posts